共 50 条
- [42] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer IN VIVO, 2018, 32 (06): : 1581 - 1586
- [47] Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer Investigational New Drugs, 2017, 35 : 642 - 648